Ethel S Gilbert

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Lung cancer risks from plutonium: an updated analysis of data from the Mayak worker cohort
    E S Gilbert
    Radiation Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20852, USA
    Radiat Res 179:332-42. 2013
  2. ncbi request reprint Health effects from fallout
    Ethel S Gilbert
    Division of Cancer Epidemiotogy and Genetics, National Cancer Institute, NIH, Rockville, MD 20852, USA
    Health Phys 82:726-35. 2002
  3. pmc Ionising radiation and cancer risks: what have we learned from epidemiology?
    Ethel S Gilbert
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA
    Int J Radiat Biol 85:467-82. 2009
  4. pmc Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update
    Ethel S Gilbert
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 7238, USA
    Radiat Res 173:659-64. 2010
  5. ncbi request reprint The impact of dosimetry uncertainties on dose-response analyses
    Ethel S Gilbert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Room 7050, Bethesda, MD 20892, USA
    Health Phys 97:487-92. 2009
  6. ncbi request reprint External dose estimation for nuclear worker studies
    E S Gilbert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
    Radiat Res 166:168-73. 2006
  7. ncbi request reprint Lung cancer after treatment for Hodgkin's disease: focus on radiation effects
    E S Gilbert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda Maryland 20852 7238, USA
    Radiat Res 159:161-73. 2003
  8. ncbi request reprint Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk
    Anil K Chaturvedi
    Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
    J Natl Cancer Inst 99:1634-43. 2007
  9. ncbi request reprint Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients
    Sara J Schonfeld
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
    J Natl Cancer Inst 98:215-8. 2006
  10. pmc Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study
    Houda Boukheris
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Int J Radiat Oncol Biol Phys 85:776-83. 2013

Detail Information

Publications23

  1. pmc Lung cancer risks from plutonium: an updated analysis of data from the Mayak worker cohort
    E S Gilbert
    Radiation Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20852, USA
    Radiat Res 179:332-42. 2013
    ..Large bioassay measurement errors alone are likely to have resulted in serious underestimation of risks, whereas other sources of uncertainty may have biased results in ways that are difficult to predict...
  2. ncbi request reprint Health effects from fallout
    Ethel S Gilbert
    Division of Cancer Epidemiotogy and Genetics, National Cancer Institute, NIH, Rockville, MD 20852, USA
    Health Phys 82:726-35. 2002
    ..Very preliminary estimates of cancer risks from fallout doses received by the United States population are presented...
  3. pmc Ionising radiation and cancer risks: what have we learned from epidemiology?
    Ethel S Gilbert
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA
    Int J Radiat Biol 85:467-82. 2009
    ..This article summarises the findings from these studies with emphasis on studies with well-characterised doses...
  4. pmc Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update
    Ethel S Gilbert
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 7238, USA
    Radiat Res 173:659-64. 2010
    ..Nevertheless, the study adds support for an increased risk of thyroid cancer due to fallout, although the data are inadequate to quantify it...
  5. ncbi request reprint The impact of dosimetry uncertainties on dose-response analyses
    Ethel S Gilbert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Room 7050, Bethesda, MD 20892, USA
    Health Phys 97:487-92. 2009
    ....
  6. ncbi request reprint External dose estimation for nuclear worker studies
    E S Gilbert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
    Radiat Res 166:168-73. 2006
    ..Based on these efforts, facility- and calendar year-specific adjustment factors have been developed, which will allow risks to be expressed as functions of organ doses with reasonable confidence...
  7. ncbi request reprint Lung cancer after treatment for Hodgkin's disease: focus on radiation effects
    E S Gilbert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda Maryland 20852 7238, USA
    Radiat Res 159:161-73. 2003
    ....
  8. ncbi request reprint Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk
    Anil K Chaturvedi
    Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
    J Natl Cancer Inst 99:1634-43. 2007
    ....
  9. ncbi request reprint Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients
    Sara J Schonfeld
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
    J Natl Cancer Inst 98:215-8. 2006
    ..The EAR of AML declined statistically significantly after 1984 (7.0 to 4.2 and 16.4 to 9.9 in the < 35 and > or = 35 age groups, respectively), which may be associated with modifications in chemotherapy...
  10. pmc Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study
    Houda Boukheris
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Int J Radiat Oncol Biol Phys 85:776-83. 2013
    ..To evaluate effects of radiation therapy, chemotherapy, cigarette smoking, and alcohol consumption on the risk of second primary salivary gland cancer (SGC) in the Childhood Cancer Survivor Study (CCSS)...
  11. pmc Stomach cancer risk after treatment for hodgkin lymphoma
    Lindsay M Morton
    Lindsay M Morton, Graça M Dores, Rochelle E Curtis, Ethel S Gilbert, Ruth A Kleinerman, and Joseph F Fraumeni Jr, National Cancer Institute, Bethesda, MD Graça M Dores, Department of Veterans Affairs Medical Center, Oklahoma City, OK Charles F Lynch, University of Iowa, Iowa City, IA Marilyn Stovall, Susan A Smith, and Rita E Weathers, University of Texas MD Anderson Cancer Center, Houston, TX Per Hall and Magnus Kaijser, Karolinska Institute, Stockholm, Sweden David C Hodgson and Eric J Holowaty, University of Toronto, Toronto, Ontario, Canada Hans H Storm, Danish Cancer Society Michael Andersson, Copenhagen University Hospital, Copenhagen, Denmark Tom Børge Johannesen and Frøydis Langmark, Cancer Registry of Norway Sophie D Fossa, Oslo University Hospital and University of Oslo, Oslo, Norway Michael Hauptmann, Alexandra W Van den Belt Dusebout, Berthe M Aleman, and Flora E van Leeuwen, Netherlands Cancer Institute, Amsterdam, National Cancer Institute of Milan
    J Clin Oncol 31:3369-77. 2013
    ..Treatment-related stomach cancer is an important cause of morbidity and mortality among the growing number of Hodgkin lymphoma (HL) survivors, but risks associated with specific HL treatments are unclear...
  12. pmc Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008
    Lindsay M Morton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Blood 121:2996-3004. 2013
    ..tAML risks should be weighed against the benefits of chemotherapy, particularly for new agents and new indications for standard agents...
  13. pmc Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix
    Anil K Chaturvedi
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
    J Clin Oncol 27:967-73. 2009
    ..We assessed whether these cofactor differences translate into differences in second cancer risk...
  14. pmc Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer
    Stefan Lonn
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland, USA
    Cancer Epidemiol Biomarkers Prev 19:464-74. 2010
    ..Adjuvant radiotherapy is common for uterine corpus cancer patients, yet the long-term carcinogenic effects of different types of radiotherapy have not been studied adequately...
  15. ncbi request reprint Leukemia following breast cancer: an international population-based study of 376,825 women
    Regan A Howard
    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7091, Bethesda, MD 20892, USA
    Breast Cancer Res Treat 105:359-68. 2007
    ....
  16. pmc Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
    Ola Landgren
    Division of Cancer Epidemiology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Blood 113:4992-5001. 2009
    ..Our findings identify subgroups of patients who underwent allogeneic HCT at elevated risk of PTLDs for whom prospective monitoring of Epstein-Barr virus activation and early treatment intervention may be particularly beneficial...
  17. ncbi request reprint Second malignant neoplasms and cardiovascular disease following radiotherapy
    Lois B Travis
    Rubin Center for Cancer Survivorship and Department of Radiation Oncology, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY Department of Radiation Oncology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA and the Dana Farber Cancer Institute, Boston, MA Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK Department of Oncology, St Jude Children s Research Hospital, Memphis, TN and the University of Tennessee Health Science Center, Memphis, TN Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA Nuclear Engineering and Engineering Physics Program, Rensselaer Polytechnic Institute, Troy, NY Department of Radiation Oncology, University of California at Davis, Davis, CA Department of Radiology, Emory University, Atlanta, GA Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY Division ofCancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD National Council on Radiation Protection and Measurements, Bethesda, MD, and the Department of Medicine, Vanderbilt University, Nashville, TN
    Health Phys 106:229-46. 2014
    ....
  18. ncbi request reprint Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1354-65. 2005
    ..Although second primary cancers are a leading cause of death among men with testicular cancer, few studies have quantified risks among long-term survivors...
  19. ncbi request reprint Lung, liver and bone cancer mortality in Mayak workers
    Mikhail E Sokolnikov
    Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Region, Russian Federation
    Int J Cancer 123:905-11. 2008
    ..These results will play an important role in plutonium risk assessment...
  20. ncbi request reprint Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma
    David C Hodgson
    Princess Margaret Hospital, University Health Network, and the Department of Radiation Oncology, University of Toronto, Canada
    J Clin Oncol 25:1489-97. 2007
    ..However, no investigation has used multivariate modeling to estimate the relative risk (RR), excess absolute risk (EAR), and cumulative incidence for specific attained ages and ages at HL diagnosis...
  21. ncbi request reprint Some statistical implications of dose uncertainty in radiation dose-response analyses
    Daniel W Schafer
    Department of Statistics, Oregon State University, Corvallis, Oregon, USA
    Radiat Res 166:303-12. 2006
    ....
  22. ncbi request reprint Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident
    Elisabeth Cardis
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 119:1224-35. 2006
    ....
  23. ncbi request reprint Interactive RadioEpidemiological Program (IREP): a web-based tool for estimating probability of causation/assigned share of radiogenic cancers
    David C Kocher
    SENES Oak Ridge, Inc, 102 Donner Drive, Oak Ridge, TN 37830, USA
    Health Phys 95:119-47. 2008
    ....